.jpg "Robyn T. Domsic, MD, MPH photo")
University of Pittsburgh
Pittsburgh, PA, United States
Dr. Domsic's research interest centers around improving the care of patients with scleroderma. Her research to date has focused on creating and testing risk stratification strategies for scleroderma patients. These tools can be used to improve both patient care and clinical trial design. Her second main area of research interest is Raynaud's phenomenon and the vascular manifestations of scleroderma. Specifically she is interested in novel imaging techniques for vascular involvement in scleroderma and assessing new outcome measures for testing therapies treating Raynaud's phenomenon.
Dr. Domsic continues to be actively involved in several multi-center clinical trials investigating potential therapies for the management of scleroderma and Raynaud phenomenon. Dr. Domsic is the Clinical Director of the UPMC and University of Pittsburgh Scleroderma Center.
Disclosure information not submitted.
Saturday, November 12, 2022
1:00 PM – 1:45 PM Eastern Time
